Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
5(25%)
Results Posted
9%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
1
5%
Ph not_applicable
12
60%
Ph early_phase_1
1
5%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 2Efficacy & side effects
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

5

trials recruiting

Total Trials

20

all time

Status Distribution
Active(5)
Completed(11)
Terminated(2)
Other(2)

Detailed Status

Completed11
Recruiting5
unknown2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
5
Success Rate
91.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (7.1%)
Phase 21 (7.1%)
N/A12 (85.7%)

Trials by Status

withdrawn15%
recruiting525%
terminated15%
completed1155%
unknown210%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT01114035Not Applicable

Characterization Phenotypic and Genetic Study of the Intestinal Epithelial Dysplasia or Tufting Enteropathy (TE)

Completed
NCT01874769

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Completed
NCT03816189

Role of Eosinophil in Fibrogenesis of Systemic Sclerosis

Completed
NCT06300697Not Applicable

Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

Recruiting
NCT02414789Not Applicable

Lyme Borreliosis and Early Cutaneous Diagnostic

Completed
NCT05111210

Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

Recruiting
NCT03921515Early Phase 1

Skin Immunity Sample Collection Involving Blisters and Biopsies

Withdrawn
NCT06111950Not Applicable

Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes

Recruiting
NCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

Recruiting
NCT06476964Not Applicable

Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics

Recruiting
NCT00367224Not Applicable

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo

Completed
NCT01950975Not Applicable

Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.

Completed
NCT06124781Not Applicable

Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).

Unknown
NCT03553823Phase 2

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Completed
NCT04459780Not Applicable

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Completed
NCT03537105Not Applicable

Analysis of Cytokine Expression Pattern in Systemic Sclerosis

Completed
NCT03976622

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

Unknown
NCT03000764Not Applicable

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer

Completed
NCT02912299

Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients

Completed
NCT01734356Not Applicable

Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells

Terminated

All 20 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
20